Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Lupus & Connective Tissue Diseases

  • 1
    News

    TNF inhibitors may dampen COVID-19 severity

    May 19, 2020

    New findings from the COVID-19 Global Rheumatology Alliance Registry.

  • News

    Advice on treating rheumatic diseases from a COVID-19 epicenter

    May 13, 2020

    Hospital for Special Surgery rheumatologists discuss their approach to caring for patients with rheumatic diseases within their practice during the COVID-19 pandemic.

  • 1
    News

    ACR gives guidance on rheumatic disease management during pandemic

    May 12, 2020

    When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be stopped or held.

  • 1
    News

    Case series suggests biologics, JAK inhibitors safe during pandemic

    May 1, 2020

    Investigators saw no increase in hospitalizations versus the general population in New York City.

  • News

    Hospitals update hydroxychloroquine protocols after FDA warning

    April 29, 2020

    Some hospitals changed their use of hydroxychloroquine for patients with COVID-19 long before the FDA’s recent warning about the drug’s risks.

  • 1
    News

    Latest data on COVID-19 patients with rheumatic diseases revealed in registry

    April 23, 2020

    Data for a total of 583 COVID-19 patients have now been made available.

  • 1
    News

    Rheumatologists seek to reassure amid hydroxychloroquine shortage

    March 26, 2020

    Rheumatologists Jill P. Buyon and Peter M. Izmirly answer questions about the availability of hydroxychloroquine during the COVID-19 pandemic, and rheumatologist Michael H. Pillinger discusses the prospects for a new trial of the gout drug colchicine in COVID-19 patients.

  • News

    Amid hydroxychloroquine hopes, lupus patients face shortages

    March 23, 2020

    Pharmacists are reporting depleted stocks of the drug, leaving many of the roughly 1.5 million lupus patients across the country unable to get their prescriptions filled. They now face an uncertain future as the public clings to one of the first signs of hope to appear since the coronavirus began sweeping across the U.S.

  • 1
    News

    Fever, intestinal symptoms may delay diagnosis of Kawasaki disease in children

    October 31, 2018

    Consider Kawasaki disease in children who present with unexplained high fever and abdominal pain.

  • 1
    News

    Few acutely ill hospitalized patients receive VTE prophylaxis

    April 2, 2018

    The results “imply that there is a significantly unmet need for effective VTE prophylaxis in both the inpatient and outpatient continuum of care.”

Previous1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences